Reduced Chlorhexidine and Daptomycin Susceptibility in Vancomycin-Resistant Enterococcus Faecium after Serial Chlorhexidine Exposure
dc.contributor.ORCID | 0000-0002-7343-9271 (Palmer, KL) | en_US |
dc.contributor.author | Bhardwaj, Pooja | en_US |
dc.contributor.author | Hans, Amrita | en_US |
dc.contributor.author | Ruikar, Kinnari | en_US |
dc.contributor.author | Guan, Ziqiang | en_US |
dc.contributor.author | Palmer, Kelli L. | en_US |
dc.contributor.utdAuthor | Bhardwaj, Pooja | en_US |
dc.contributor.utdAuthor | Hans, Amrita | en_US |
dc.contributor.utdAuthor | Ruikar, Kinnari | en_US |
dc.contributor.utdAuthor | Palmer, Kelli L. | en_US |
dc.date.accessioned | 2018-10-22T19:36:48Z | |
dc.date.available | 2018-10-22T19:36:48Z | |
dc.date.created | 2018-01 | en_US |
dc.date.issued | 2018-10-22 | |
dc.description.abstract | Vancomycin-resistant Enterococcus faecium strains (VREfm) are critical public health concerns because they are among the leading causes of hospital-acquired bloodstream infections. Chlorhexidine (CHX) is a bisbiguanide cationic antiseptic that is routinely used for patient bathing and other infection control practices. VREfm are likely frequently exposed to CHX; however, the long-term effects of CHX exposure have not been studied in enterococci. In this study, we serially exposed VREfm to increasing concentrations of CHX for a period of 21 days in two independent experimental evolution trials. Reduced CHX susceptibility emerged (4-fold shift in CHX MIC). Subpopulations with reduced daptomycin (DAP) susceptibility were detected, which were further analyzed by genome sequencing and lipidomic analysis. Across the trials, we identified adaptive changes in genes with predicted or experimentally confirmed roles in chlorhexidine susceptibility (efrE), global nutritional stress response (relA), nucleotide metabolism (cmk), phosphate acquisition (phoU), and glycolipid biosynthesis (bgsB), among others. Moreover, significant alterations in membrane phospholipids were identified for some populations with reduced DAP susceptibility. Our results are clinically significant because they identify a link between serial subinhibitory CHX exposure and reduced DAP susceptibility. In addition, the CHX-induced genetic and lipidomic changes described in this study offer new insights into the mechanisms underlying the emergence of antibiotic resistance in VREfm. | en_US |
dc.description.department | School of Natural Sciences and Mathematics | en_US |
dc.description.sponsorship | NIH grant nos. GM-069338 and EY023666 | en_US |
dc.identifier.bibliographicCitation | Bhardwaj, Pooja, Amrita Hans, Kinnari Ruikar, Ziqiang Guan, et al. 2018. "Reduced chlorhexidine and daptomycin susceptibility in vancomycin-resistant enterococcus faecium after serial chlorhexidine exposure." Antimicrobial Agents and Chemotherapy 62(1), doi:10.1128/AAC.01235-17 | en_US |
dc.identifier.issn | 0066-4804 | en_US |
dc.identifier.issue | 1 | en_US |
dc.identifier.uri | http://hdl.handle.net/10735.1/6225 | |
dc.identifier.volume | 62 | en_US |
dc.language.iso | en | en_US |
dc.publisher | Amer Soc Microbiology | en_US |
dc.relation.uri | http://dx.doi.org/10.1128/AAC.01235-17 | |
dc.rights | CC BY 4.0 (Attribution) | en_US |
dc.rights | ©2017 The Authors | en_US |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | en_US |
dc.source | Antimicrobial Agents and Chemotherapy | |
dc.subject | Daptomycin | en_US |
dc.subject | Cross Infection | en_US |
dc.subject | Bloodborne infections | en_US |
dc.subject | Critically ill | en_US |
dc.subject | Patients | en_US |
dc.subject | Staphylococcus aureus | en_US |
dc.subject | Cardiolipin | en_US |
dc.subject | Escherichia coli | en_US |
dc.subject | Microbiology | en_US |
dc.subject | Enterococcus | en_US |
dc.subject | Chlorhexidine | en_US |
dc.subject | Enterococcus faecalis | en_US |
dc.title | Reduced Chlorhexidine and Daptomycin Susceptibility in Vancomycin-Resistant Enterococcus Faecium after Serial Chlorhexidine Exposure | en_US |
dc.type.genre | article | en_US |
Files
Original bundle
1 - 4 of 4
Loading...
- Name:
- NSM-4295-8383.73.pdf
- Size:
- 825.55 KB
- Format:
- Adobe Portable Document Format
- Description:
- Article
Loading...
- Name:
- NSM-4295-8383.73_S1.pdf
- Size:
- 2.19 MB
- Format:
- Adobe Portable Document Format
- Description:
- Supplement 1
No Thumbnail Available
- Name:
- NSM-4295-8383.73_S2.ods
- Size:
- 36.17 KB
- Format:
- OpenDocument Spreadsheet
- Description:
- Supplement 2
No Thumbnail Available
- Name:
- NSM-4295-8383.73_S3.ods
- Size:
- 18.53 KB
- Format:
- OpenDocument Spreadsheet
- Description:
- Supplement 3